Before you sell to, join or invest in Lonestar Medicines, Inc.
MentionFox check on Lonestar Medicines, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/lonestar-medicines-inc-form-d-26000001
Check Lonestar Medicines, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Lonestar Medicines, Inc.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
Lonestar Medicines, Inc. filed a Form D with the Securities and Exchange Commission on 2026-02-23.
Lonestar Medicines, Inc. filed a Form D notice of an exempt securities offering with the SEC on February 23, 2026. The filing reports $25M sold. Its industry group is Biotechnology. It names Stephen Thomas (Executive Officer, Director, Promoter), William Bonificio (Executive Officer, Promoter), Naveen Daryani (Executive Officer) (SEC Form D, February 23, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Lonestar Medicines, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-02-23 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Lonestar Medicines, Inc.
Free to see. No signup.
More on the people and the money behind Lonestar Medicines, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in February 2026, largest first.
Get an email when Lonestar Medicines, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Lonestar Medicines, Inc. raises, hires or launches. No email unless you switch it on.
Watch Lonestar Medicines, Inc. →Get the full cited report on Lonestar Medicines, Inc.
What the filing shows about Lonestar Medicines, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Lonestar Medicines, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Lonestar Medicines, Inc.'s address as 200 Berkeley Street, 18TH Floor, Boston, MA 02116.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Lonestar Medicines, Inc. See pricing
Lonestar Medicines, Inc. is a registered filer with the SEC (CIK 2111460) and has filed since 2026-02-23. 1 filing is on record, the latest on 2026-02-23.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Lonestar Medicines, Inc.'s Form D of 2026-02-23 names Stephen Thomas, William Bonificio, Naveen Daryani and 2 more as its officers, directors or promoters.
Its new offerings report $25M sold across 1 offering, as its own filings state.
Trailing twelve months. 766 filings in Biotechnology, totalled by week. The dot is this raise, $25M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Stephen Thomas is named as Executive Officer and Director and Promoter on the Form D that Lonestar Medicines, Inc. filed with the SEC on 23 February 2026, one of 5 people that filing names.
William Bonificio is named as Executive Officer and Promoter on the Form D that Lonestar Medicines, Inc. filed with the SEC on 23 February 2026, one of 5 people that filing names.
Naveen Daryani is named as Executive Officer on the Form D that Lonestar Medicines, Inc. filed with the SEC on 23 February 2026, one of 5 people that filing names.
Andrew Levin is named as Director on the Form D that Lonestar Medicines, Inc. filed with the SEC on 23 February 2026, one of 5 people that filing names.
Gianna Hoffman-Luca is named as Director on the Form D that Lonestar Medicines, Inc. filed with the SEC on 23 February 2026, one of 5 people that filing names.
5 people named on the filing — 3 holding an executive role and 2 as directors only.
Named as of the 2026-02-23 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Lonestar Medicines, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Lonestar Medicines, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Lonestar Medicines, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Lonestar Medicines, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Lonestar Medicines, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Lonestar Medicines, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/lonestar-medicines-inc-form-d-26000001